GLYXAMBI® on PBS SGLT2i + DPP4i combination containing JARDIANCE® and TRAJENTA®

5 minute read

SPONSORED

By

Sponsored

Clinicians have welcomed the Pharmaceutical Benefits Scheme (PBS) listing of the type 2 diabetes medicine that combines JARDIANCE® (empagliflozin) and TRAJENTA® (linagliptin) in a once-daily tablet

This content is for AHPRA registered professionals only.
Join Now

End of content

No more pages to load

Log In Register ×